MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

23 May 2024 Evaluate
The sales surged to Rs. 1270.62 millions, up 26.66% for the March 2024 quarter as against Rs. 1003.17 millions during the corresponding quarter previous year.A humble growth in net profit of 7.59% reported in the quarter ended March 2024 to Rs. 136.59  millions from Rs. 126.95 millions.The company reported a good operating profit of 211.88 millions compared to 177.98 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1270.62 1003.17 26.66 4212.30 3796.36 10.96 4212.30 3796.36 10.96
Other Income 49.51 48.19 2.74 163.48 145.42 12.42 163.48 145.42 12.42
PBIDT 211.88 177.98 19.05 681.59 589.34 15.65 681.59 589.34 15.65
Interest 0.49 0.17 188.24 1.57 0.77 103.90 1.57 0.77 103.90
PBDT 211.39 177.81 18.89 680.02 588.57 15.54 680.02 588.57 15.54
Depreciation 15.34 13.10 17.10 60.57 52.12 16.21 60.57 52.12 16.21
PBT 196.05 164.71 19.03 619.45 536.45 15.47 619.45 536.45 15.47
TAX 59.46 37.76 57.47 169.73 138.10 22.90 169.73 138.10 22.90
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 136.59 126.95 7.59 449.72 398.35 12.90 449.72 398.35 12.90
Equity 28.91 29.23 -1.09 28.91 29.23 -1.09 28.91 29.23 -1.09
PBIDTM(%) 16.68 17.74 -6.01 16.18 15.52 4.23 16.18 15.52 4.23
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..